Concord Medical Co., Ltd. (TPEX:6518)

Market Cap	906.67M +4.6%
Revenue (ttm)	905.31M +4.9%
Net Income	54.73M +16.4%
EPS	1.64 +16.3%
Shares Out	33.33M
PE Ratio	16.59
Forward PE	n/a
Dividend	1.10 (4.04%)
Ex-Dividend Date	Apr 10, 2025

Volume	6,000
Average Volume	12,503
Open	27.10
Previous Close	27.20
Day's Range	27.10 - 27.20
52-Week Range	22.80 - 28.40
Beta	0.34
RSI	60.26
Earnings Date	Mar 6, 2026

About Concord Medical

Concord Medical Co., Ltd. provides hospital management support services primarily in Taiwan. The company offers medical management services that include medical training and nursing staffing and assisting on medical management; and procurement services for instruments and equipment, drugs, medical materials and consumables, testing equipment, and reagents and consumables, as well as develops its own brand for medical aesthetic skincare products, health foods, and topical Chinese medicine products. It is also involved in the medical equipment pl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6518

Financial Performance

In 2024, Concord Medical's revenue was 889.85 million, an increase of 6.80% compared to the previous year's 833.20 million. Earnings were 49.57 million, an increase of 15.97%.